Clinical Trials and Evidence: STEP Program The Semaglutide Treatment Effect in People with Obesity (STEP) trials provide the strongest evidence for Semaglutide for Obesity This evidence shows that Semaglutide for Obesity is not only effective but also sustainable for long-term management
Medications such as semaglutide (Wegovy) and liraglutide (Saxenda) are licensed for weight management, while other GLP-1 receptor agonists like dulaglutide (Trulicity) are licensed only for type 2 diabetes in the UK
Cost of Our Wellness Program in Portland, Oregon Our wellness program is a cash or credit card-only subscription service
Tirzepatide and GIP in Covid-19 GIP is also known as a gastric inhibitory polypeptide, secreted from K cells and found in the mucosa of the jejunum and duodenum
Type 2 diabetes is not a single condition but rather the combined result of at least eight different disorders, referred to as the Ominous Octet in the 2008 American Diabetes Association Banting Lecture by Ralph DeFronzo, MD, professor of medicine, chief of the Diabetes Division in the Joe R
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug